Your browser doesn't support javascript.
loading
Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow, Maria; Langa, Paulina; Harasymczuk, Michal; Cwykiel, Joanna; Sielewicz, Magdalena; Smieszek, Jaroslaw; Heydemann, Ahlke.
Afiliação
  • Siemionow M; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Langa P; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Harasymczuk M; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Cwykiel J; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Sielewicz M; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Smieszek J; Department of Orthopaedics, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Heydemann A; Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, Illinois, USA.
Stem Cells Transl Med ; 10(10): 1406-1418, 2021 10.
Article em En | MEDLINE | ID: mdl-34291884

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofina / Distrofia Muscular de Duchenne Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article